Key pathways activated in neoplasias by BAs are regulated by nuclear receptors, FXR, CAR, SHP, PXR, LXR and VDR and other membrane receptors such as S1PR2, TGR5, CHRM2 and CHRM3. Here, CHRM2 is linked to neoplasm.